HomeMTNB • NYSEAMERICAN
add
Matinas BioPharma Holdings Inc
Previous close
$1.74
Day range
$1.61 - $1.80
Year range
$0.47 - $4.19
Market cap
9.00M USD
Avg Volume
52.28K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.84M | -25.57% |
Net income | -5.24M | 8.29% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.82M | 68.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.52M | -54.41% |
Total assets | 11.42M | -53.11% |
Total liabilities | 3.75M | -28.75% |
Total equity | 7.68M | — |
Shares outstanding | 5.09M | — |
Price to book | 1.15 | — |
Return on assets | -39.15% | — |
Return on capital | -47.87% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.24M | 8.29% |
Cash from operations | -2.02M | 34.93% |
Cash from investing | — | — |
Cash from financing | 1.62M | -82.35% |
Net change in cash | -399.00K | -112.69% |
Free cash flow | -1.41M | -63.55% |
About
Founded
2013
Headquarters
Website
Employees
3
